Recent Finacing
Recent Raise
gIcare Pharma develops GIC-1001, an oral, peripherally-acting opioid agonist targeting colonic mu and kappa receptors to enable sedation-free colonoscopy and treat gastrointestinal disorders like IBS.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors